Registry Study for Radiation Therapy Outcomes

Conditions

Neoplasms

Keywords

cancer, proton, radiation

Brief summary

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Michael D. Chuong, Amanda Zakka, Robert A. Herrera, Muni Rubens, Arpit Chhabra et al. (13 authors)

Advances in Radiation Oncology2026-08-28

10.1016/j.adro.2026.102133

Evaluation of the utility of rescans in the treatment of prostate and pelvic nodes with pencil beam scanning protons.

Campbell LE, Laub SJ, Smith JA, Hartsell WF.

2023-12-15

10.1016/j.meddos.2023.10.012

Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.

Saeed AM, Khairnar R, Sharma AM, Larson GL, Tsai HK, Wang CJ, Halasz LM, Chinnaiyan P, Vargas CE, Mishra MV.

2020-04-2222 citations

10.1016/j.adro.2020.03.022

Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09.

Mishra MV, Khairnar R, Bentzen SM, Larson G, Tsai H, Sinesi C, Vargas C, Laramore G, Rossi C, Rosen L, Sun K, Hartsell W.

2020-03-079 citations

10.1016/j.ctro.2020.03.003

Minimal acute toxicity from proton beam therapy for major salivary gland cancer

Michael D. Chuong, John Michael Bryant, William F. Hartsell, Gary Larson, Shahed N. Badiyan et al. (9 authors)

Acta Oncologica2019-12-0533 citations

10.1080/0284186x.2019.1698764

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

Lee HJ, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J.

2018-09-173 citations

10.1186/s13014-018-1127-6

Proton beam therapy for liver cancer is well tolerated: Outcomes from the Proton Collaborative Group REG001-09 trial.

Michael D. Chuong, Smith Apisarnthanarax, William F. Hartsell, Gary Larson, Henry Tsai et al. (7 authors)

Journal of Clinical Oncology2017-02-01

10.1200/jco.2017.35.4_suppl.389

Interventions

RADIATIONProton Therapy, Photon Therapy, SRS, Brachytherapy

Outcomes Tracking

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

No

Inclusion criteria

* Planned treatment with radiation therapy * Ability to understand and sign IRB approved consent

Design outcomes

Primary

Measure	Time frame
Define outcomes for patients treated at participating institutions	PRN

Secondary

Measure	Time frame
Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures	Annually PRN
Improve patient care by an adequate understanding of the results and patient population at participating institutions	Reviewed Annually PRN

Countries

United States

Contacts

STUDY_CHAIRCarlos Vargas, MD

Proton Collaborative Group

Outcome results

None listed